Matt Wien

Papers

Total Citations

H-Index

About

Matt Wien is a leading researcher in the field of health-system pharmacy, with a primary focus on the safety, efficiency, and economic impact of automated medication compounding—particularly for hazardous antineoplastic agents. His most influential work, the 2012 study "Impact of Robotic Antineoplastic Preparation on Safety, Workflow, and Costs" (73 citations), provides a landmark evaluation of robotic technology in pharmacy practice. This research systematically demonstrated that robotic compounding not only reduces staff exposure to toxic drugs and minimizes medication errors but also streamlines pharmacy workflow and can lower overall operational costs. Wien’s contributions have been instrumental in guiding hospitals and health systems toward adopting automation to enhance both occupational safety and patient care quality. By rigorously analyzing the trade-offs between capital investment and long-term savings, his work has shaped best practices in sterile compounding and influenced policy decisions in oncology pharmacy. For students and researchers, Wien’s studies offer a compelling model for translating engineering solutions into measurable clinical and financial outcomes, highlighting the critical role of pharmacy innovation in modern healthcare.